Quest Diagnostics Incorporated Stock Today
| DGX Stock | USD 125.91 1.07 0.84% |
Performance0 of 100
| Odds Of DistressLess than 8
|
Quest Diagnostics is trading at 125.91 as of the 19th of April 2024; that is -0.84 percent down since the beginning of the trading day. The stock's open price was 126.98. Quest Diagnostics has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Quest Diagnostics Incorporated are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of December 1996 | Category Healthcare | Classification Health Care |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. The company has 111.06 M outstanding shares of which 2.55 M shares are currently shorted by investors with about 2.81 days to cover. More on Quest Diagnostics Incorporated
Moving against Quest Stock
| 0.6 | TIL | Instil Bio Financial Report 9th of May 2024 | PairCorr |
| 0.42 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Quest Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Quest Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Quest Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO | Stephen Rusckowski | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Diploma Group Limited | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Quest Diagnostics report their recommendations after researching Quest Diagnostics' financial statements, talking to executives and customers, or listening in on Quest Diagnostics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Quest Diagnostics. The Quest consensus assessment is calculated by taking the average forecast from all of the analysts covering Quest Diagnostics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Quest Diagnostics' liquidity, profitability, solvency, and operating efficiency, Quest Diagnostics Incorporated is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Quest Diagnostics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quest Diagnostics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Quest Diagnostics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Quest Diagnostics' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Quest Diagnostics' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Quest Diagnostics' financial leverage. It provides some insight into what part of Quest Diagnostics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quest Diagnostics Incorporated (DGX) is traded on New York Stock Exchange in USA. It is located in 500 Plaza Drive, Secaucus, NJ, United States, 07094 and employs 40,000 people. Quest Diagnostics is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 13.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest Diagnostics's market, we take the total number of its shares issued and multiply it by Quest Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Quest Diagnostics runs under Health Care Providers & Services sector within Health Care industry. The entity has 111.06 M outstanding shares of which 2.55 M shares are currently shorted by investors with about 2.81 days to cover.
Quest Diagnostics Incorporated has about 315 M in cash with 1.27 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.15.
Check Quest Diagnostics Probability Of Bankruptcy
Ownership AllocationQuest Diagnostics has a total of 111.06 Million outstanding shares. The majority of Quest Diagnostics Incorporated outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quest Diagnostics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quest Diagnostics. Please pay attention to any change in the institutional holdings of Quest Diagnostics as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Quest Ownership Details
Quest Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Quest Diagnostics jumping above the current price in 90 days from now is about 76.81%. The Quest Diagnostics Incorporated probability density function shows the probability of Quest Diagnostics stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Quest Diagnostics Incorporated has a beta of -0.0964 suggesting as returns on the benchmark increase, returns on holding Quest Diagnostics are expected to decrease at a much lower rate. During a bear market, however, Quest Diagnostics Incorporated is likely to outperform the market. Additionally, quest Diagnostics Incorporated has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Quest Diagnostics to move above the current price in 90 days from now is about 76.81 (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Stock to fall within a particular range of prices over 90 days) .
Quest Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Quest Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Quest Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Quest Diagnostics' value.| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.9 M | |
| Amvescap Plc. | 2023-12-31 | 1.7 M | |
| Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 1.7 M | |
| Wells Fargo & Co | 2023-12-31 | 1.5 M | |
| Fmr Inc | 2023-12-31 | 1.3 M | |
| Northern Trust Corp | 2023-12-31 | 1.1 M | |
| Bank Of America Corp | 2023-12-31 | 1 M | |
| Legal & General Group Plc | 2023-12-31 | 1 M | |
| Ameriprise Financial Inc | 2023-12-31 | 1 M | |
| Vanguard Group Inc | 2023-12-31 | 13.6 M | |
| Blackrock Inc | 2023-12-31 | 10.6 M |
Quest Diagnostics Historical Income Statement
Quest Diagnostics Incorporated Income Statement is one of the three primary financial statements used for reporting Quest's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Quest Diagnostics revenue and expense. Quest Diagnostics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 18.8 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 280.4 M in 2024. View More FundamentalsQuest Stock Against Markets
Picking the right benchmark for Quest Diagnostics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Quest Diagnostics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Quest Diagnostics is critical whether you are bullish or bearish towards Quest Diagnostics Incorporated at a given time. Please also check how Quest Diagnostics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Quest Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Quest Diagnostics Corporate Directors
Quest Diagnostics corporate directors refer to members of a Quest Diagnostics board of directors. The board of directors generally takes responsibility for the Quest Diagnostics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Quest Diagnostics' board members must vote for the resolution. The Quest Diagnostics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gail Wilensky | Independent Director | Profile | |
| Wright Lassiter | Independent Director | Profile | |
| Gary Pfeiffer | Independent Director | Profile | |
| Vicky Gregg | Independent Director | Profile |
How to buy Quest Stock?
Before investing in Quest Diagnostics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Quest Diagnostics. To buy Quest Diagnostics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Quest Diagnostics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Quest Diagnostics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Quest Diagnostics Incorporated stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Quest Diagnostics Incorporated stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Quest Diagnostics Incorporated, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Quest Stock please use our How to Invest in Quest Diagnostics guide.
Already Invested in Quest Diagnostics Incorporated?
The danger of trading Quest Diagnostics Incorporated is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Quest Diagnostics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Quest Diagnostics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Quest Diagnostics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.868 | Dividend Share 2.84 | Earnings Share 7.49 | Revenue Per Share 82.607 | Quarterly Revenue Growth (0.02) |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.